Solutions & Services
Therapeutic expertise
Why APICES
We want to share the acknowledgment that APICES has received in a fertility retrospective study in the recent paper published in The Journal of Obstetrics and Gynaecology, in which APICES has collaborated in medical writing activities.
This means a great motivation to all the APICES team to give continuity to the implication we have in every project in which we collaborate. APICES is very proud of the recognition of our work, and we would like to thank Dra. Mariola Hernández Martínez, and Ferring for giving us the opportunity to appear in the acknowledgments of the publication and congratulate them and all the investigators for their project success.
This retrospective study aims to evaluate obstetric outcomes and the onset of menopause in patients with Hodgkin and non-Hodgkin lymphoma, by analyzing electronic medical records of individuals who attended the Haematology Department at the study site between 2000 and 2018, with follow-up data collected until December 2023.
You can find further information in the following link: https://www.tandfonline.com/doi/full/10.1080/01443615.2025.2449679#abstract
Get the latest clinical insights delivered to your feed or inbox!
On integration, change leadership, and strengthening Apices as one unified organization In a clinical research environment where sponsors value stability, predictability, and quality above all else, organizational change must be approached with care. As APICES...
RWE and HEOR have moved from supporting inputs to decision-critical evidence across development and access. This article summarises what teams are using them for today, how evidence generation is changing, and where AI adds value when paired with the right governance.
Stage III NSCLC care sits at the intersection of multimodal treatment and real-world constraints. The GEOCP-SEOR population-based study describes how patients are managed across Spain, and APICES was acknowledged for supporting the publication through medical editorial assistance.